Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.73 USD | -11.47% | -26.69% | +28.90% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.90% | 12.13M | |
+22.56% | 46.71B | |
+48.83% | 41.8B | |
-1.51% | 41.52B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
-0.14% | 12.14B | |
-0.47% | 12.08B | |
+26.45% | 11.98B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Therapeutics Plans 1-for-240 Reverse Stock Split